{
  "id": "acute_pancreatitis_criteria",
  "type": "diagnostic_criteria",
  "name": "Acute Pancreatitis - Diagnosis and Management",
  "content": "ACUTE PANCREATITIS:\n\nDEFINITION:\n- Acute inflammation of the pancreas\n- May involve peripancreatic tissues or remote organ systems\n\nDIAGNOSTIC CRITERIA (Requires ≥2 of 3):\n1. Characteristic abdominal pain (severe, epigastric, radiating to back)\n2. Serum lipase (or amylase) ≥3 times upper limit of normal\n3. Characteristic findings on imaging (CT, MRI, or US)\n\nETIOLOGY:\n- Gallstones (40-50%) - most common\n- Alcohol (25-35%) - second most common\n- Hypertriglyceridemia (TG >1000 mg/dL)\n- Post-ERCP (3-5% of procedures)\n- Medications (azathioprine, 6-MP, valproic acid, sulfonamides, thiazides, pentamidine)\n- Hypercalcemia\n- Trauma\n- Autoimmune\n- Genetic (PRSS1, SPINK1, CFTR mutations)\n- Idiopathic (10-20%)\n\nCLINICAL PRESENTATION:\n- Severe epigastric pain, constant, radiating to back\n- Nausea, vomiting\n- Abdominal tenderness, guarding\n- Decreased bowel sounds\n- Cullen sign (periumbilical ecchymosis) or Grey Turner sign (flank ecchymosis) - suggests hemorrhagic pancreatitis\n\nLABORATORY:\n- Lipase: More specific than amylase, remains elevated longer\n- Amylase: Less specific (also elevated in bowel perforation, ischemia)\n- Degree of elevation does NOT correlate with severity\n- CMP: Assess for hypocalcemia, hyperglycemia, AKI\n- CBC: Leukocytosis, hemoconcentration\n- LFTs: Elevated if biliary etiology (ALT >3× suggests gallstone)\n- Triglycerides: If >1000, likely causative\n- Lactate, calcium (prognostic)\n\nIMAGING:\n\nInitial:\n- RUQ ultrasound: Identify gallstones, CBD dilation\n- CT abdomen with IV contrast: Not needed for diagnosis, reserve for:\n  * Diagnostic uncertainty\n  * No improvement after 48-72 hours\n  * Clinical deterioration\n  * Assess for complications (necrosis, fluid collections)\n\nTiming:\n- Delay CT until 48-72h after onset for accurate assessment of necrosis\n\nMRI/MRCP:\n- If concern for choledocholithiasis\n- Better for ductal anatomy\n\nSEVERITY CLASSIFICATION (Revised Atlanta 2012):\n\n1. MILD:\n   - No organ failure\n   - No local or systemic complications\n   - Usually resolves in <1 week\n\n2. MODERATELY SEVERE:\n   - Transient organ failure (<48h) OR\n   - Local complications (fluid collections, pseudocyst) OR\n   - Exacerbation of comorbidities\n\n3. SEVERE:\n   - Persistent organ failure (>48h)\n   - Single or multiple organ failure\n   - Mortality 20-30%\n\nORGAN FAILURE (Modified Marshall Score ≥2):\n- Cardiovascular: SBP <90 mmHg\n- Respiratory: PaO2/FiO2 ≤300\n- Renal: Creatinine ≥2.0 mg/dL\n\nPROGNOSTIC SCORING:\n\nRanson Criteria (0-11 points):\nAt admission:\n- Age >55, WBC >16K, glucose >200, LDH >350, AST >250\n\nAt 48h:\n- Hct drop >10%, BUN rise >5, Ca <8, PaO2 <60, Base deficit >4, Fluid sequestration >6L\n\nScore ≥3: Severe pancreatitis\n\nBISAP Score (0-5 points):\n- BUN >25\n- Impaired mental status (GCS <15)\n- SIRS (≥2 criteria)\n- Age >60\n- Pleural effusion\n\nScore ≥3: Increased mortality\n\nLOCAL COMPLICATIONS:\n\n1. Acute peripancreatic fluid collections (APFC):\n   - <4 weeks, no wall\n   - Most resolve spontaneously\n\n2. Pancreatic pseudocyst:\n   - >4 weeks, well-defined wall, no solid material\n   - Treatment if symptomatic, infected, or enlarging\n\n3. Acute necrotic collection (ANC):\n   - <4 weeks, necrosis + fluid\n   \n4. Walled-off necrosis (WON):\n   - >4 weeks, necrosis with encapsulating wall\n   - Infected necrosis requires debridement (endoscopic, percutaneous, or surgical)\n\nSYSTEMIC COMPLICATIONS:\n- ARDS, respiratory failure\n- AKI\n- Shock\n- Sepsis\n- GI bleeding\n- Splanchnic vein thrombosis\n\nMANAGEMENT:\n\n1. SUPPORTIVE CARE:\n   - Aggressive IV fluid resuscitation: LR 250-500 mL/h (5-10 mL/kg/h)\n   - Goal: UOP >0.5 mL/kg/h, Hct 35-44%\n   - Avoid overresuscitation (↑ abdominal compartment syndrome)\n   \n2. PAIN CONTROL:\n   - Opioids (no evidence morphine worsens outcomes)\n   - PCAs for severe pain\n\n3. NUTRITION:\n   - Early enteral nutrition (within 24-48h) reduces infection, mortality\n   - Oral diet as tolerated (no need to wait for lipase normalization)\n   - If unable to tolerate PO: Nasogastric or nasojejunal tube\n   - TPN only if enteral feeding fails\n\n4. ANTIBIOTICS:\n   - NOT indicated for prophylaxis in sterile necrosis\n   - Only if: Infected necrosis, cholangitis, extrapancreatic infection\n   - Empiric if suspected infected necrosis: Carbapenem or fluoroquinolone + metronidazole\n\n5. GALLSTONE PANCREATITIS:\n   - ERCP within 24h if cholangitis or persistent CBD obstruction\n   - Cholecystectomy during same hospitalization (if mild) or after 6 weeks (if severe)\n   - Delay if necrotizing pancreatitis\n\n6. COMPLICATIONS:\n   - Infected necrosis: Step-up approach (percutaneous drainage → minimally invasive debridement → open necrosectomy)\n   - Persistent organ failure: ICU care, mechanical ventilation, dialysis, vasopressors\n\nPREVENTION (If recurrent):\n- Gallstones: Cholecystectomy\n- Alcohol: Abstinence\n- Hypertriglyceridemia: Fibrates, omega-3 fatty acids, goal TG <500\n- Medication-induced: Discontinue offending agent\n\nPROGNOSIS:\n- Mild: Mortality <1%\n- Severe: Mortality 20-30%\n- Infected necrosis: Mortality up to 40%",
  "metadata": {
    "category": "gastrointestinal",
    "diagnosis": "acute_pancreatitis",
    "priority": "HIGH",
    "source": "ACG Acute Pancreatitis Guidelines 2013, Revised Atlanta Classification 2012"
  }
}
